Sarepta Therapeutics Inc
NASDAQ: SRPT
$119.02
+$4.94 (+4.3%)
Closing Price on February 5, 2025
SRPT Articles
These four biotech companies not only have data that could prove to be huge, but they have been absolutely hammered over the past year, offering aggressive accounts the best entry points in some time.
Published:
Last Updated:
Here are three biotechs that just recently announced successful Phase 2 trial data for drugs with very big addressable markets.
Published:
Last Updated:
Sarepta Therapeutics Inc. (NASDAQ: SRPT) has seen more than its fair share of volatility in the market of late. Now shares are surging after it has reached a compromise with the U.S. Food and Drug...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include First Data, General Electric, Sarepta Therapeutics, Western Digital, Walgreens Boots Alliance and Zillow.
Published:
Last Updated:
Sarepta Therapeutics and Globalstar are among the companies that punished shareholder the most this past week.
Published:
Last Updated:
Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares saw a handy gain on Wednesday following an analyst upgrade from Janney Montgomery Scott.
Published:
Last Updated:
Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.
Published:
Last Updated:
Apple, Twitter and other companies punished shareholders last week, and analysts expect more earnings disappointments going forward.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital and Whiting Petroleum.
Published:
Last Updated:
April 26, 2016: Here are four stocks trading with relatively heavy volume among 14 equities making new 52-week lows in Tuesday’s session. NYSE advancing stocks led decliners by about 3 to 1 while...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Broadcom, Caterpillar, Sirius XM, Newmont, Palo Alto, Perrigo, Sarepta and Xerox.
Published:
Last Updated:
Although the markets have made their comeback, some stocks are still slowing that recovery and punishing their shareholders. Last week that included Netflix and Sarepta Therapeutics.
Published:
Last Updated:
Sarepta Therapeutics shares got crushed on Thursday and then exploded on Friday following the FDA view on its Duchenne muscular dystrophy treatment.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include ArcelorMittal, Boeing, Intel, Johnson & Johnson, Schlumberger, Yahoo and Vivint Solar.
Published:
Last Updated:
After a week when the indexes finally fought their way back to even for 2016, one probably would think that insiders would be selling the huge rally. Just the opposite happened.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.